The brain is the command center of our bodies, integrating information from the periphery and providing sophisticated control over behavior. The brain stores memories and is considered to determine who we are. This concept goes hand in hand with an important feature of the brain: neurons are some of the few cell types in the body that do not divide once they have matured, meaning that the sets of neurons generated during our in utero and early postnatal development are the only building blocks of the brain. Or so it was thought.
We were intrigued by these findings and keen to apply our system to understand how FGF2 regulates neural growth in vivo. There was a challenge, though: unlike NGF, which is readily secreted when expressed in cells, FGF2 is not secreted. To promote its secretion, we decided to put the NGF signal sequence in front of the FGF2 clone, and we expressed this construct in cultured fibroblasts. To confirm that such modified FGF2 retained its axon-promoting action, we put the media conditioned by the fibroblasts on primary hippocampal neuronal cultures. We were surprised when, instead of axon elongations, we saw a wave of cells dividing in the dish. It turned out that the addition of our conditioned media pushed the neural progenitor cells that are found in hippocampal cultures into division. This result was, at the same time, exciting and unnerving. Given this strong proliferative effect, we were wondering whether the transfection of the construct, which was derived from a retrovirus as it was done at those times, may have transformed the fibroblasts, prompting them into releasing another, perhaps yet unknown growth factor. However, it soon became clear that we were indeed looking at FGF2, and in fact, it turned out that FGF2 had the ability to promote distinct effects depending on its concentration: at low doses, it induced axon elongation, and at high doses, it acted to promote neural progenitor proliferation. We were, however, still puzzled by this unexpected ability of FGF2 to act on neural cell proliferation, given that Samuel Weiss and Brent Reynolds subsequently published research showing that the epidermal growth factor (EGF) was a mitogen for neural progenitor cells derived from the subventricular zone, another neurogenic region in the brain. It may seem naive these days, but at the time, we worked under the assumption that growth factors had non-overlapping biological roles, and the idea that the same growth factor might facilitate two fundamentally distinct processes such as differentiation and proliferation in the same cellular population was somewhat surprising to us. Such a result, however, strengthened our resolve to understand the roles of FGF2 in vivo and, in particular, to discern whether it was able to promote proliferation of neural progenitors. Two relentless and resourceful post docs in my laboratory-Gerd Kempermann and Georg Kuhntook up this task in the early 1990s. Their goal was to transplant FGF2-expressing fibroblasts into the neurogenic zone of the adult hippocampus that Altman had described, trying to see if the released FGF2 would prompt their proliferation. Having chosen the experimental system, Gerd and Georg quickly realized that they also needed a reliable means to monitor neurogenesis in vivo and therefore explored the methods that were available at the time. To label proliferating cells, scientists then and now take advantage of the ability to trace DNA synthesis occurring during the duplication of the genome. At that time, one labeled newly synthesized DNA by attaching a radioactive analog of one of the DNA building blocks, such as tritiated thymidine, which became incorporated into the nascent DNA and could be detected as speckles in newly born cells. However, when we took a close look at this method, we found that the readout was not sufficiently quantitative to determine the numbers of proliferative events in individual cells. We also needed to identify the types of cells that were proliferating and their ultimate fate. This step was particularly important, given that we wanted to understand whether growth factors acted on a specific cell population within the brain, such as neuronal progenitors, glial cells or perhaps fibroblasts. Luckily, Alan Smith and colleagues had just discovered that the antibody against the nuclear antigen NeuN labeled specifically the nuclei of neurons, which would allow us to detect neurons Rusty and personal editor Mary Lynn-drinking beer and wearing silly hats.
derived from proliferating cells. Eager to take advantage of this exciting finding, we asked Alan for an aliquot of his new antibody, which he kindly shared with us (and which still exists in our lab fridge). However, the methods developed for the detection of radioactive tritium in brain sections did not allow double labeling with antibodies, due to the tissue fixation required for radiography. To our rescue came a methodology that had also been recently developed and also relied on the detection of newly synthesized DNA. Richard Nowakowski and colleagues found that a nonradioactive nucleotide analog, bromodeoxyuridine (BrDU), could be used to track proliferating cells in the developing mouse brain and that it could be detected with antibodies. This was a major technical breakthrough, because it allowed us to combine BrDU labeling with antibodies against NeuN, as well as GFAP, and other molecules associated with specific cell populations and to discern the cells that proliferated in response to growth factors and determine their fate. Our research was greatly facilitated by another emerging technology, 3D confocal microscopic imaging, which allowed us to examine the distribution of cells that incorporated BrDU in the tissue and to generate reliable numbers using quantitative stereology.
Looking back, I am struck by the confluence of methodological advances that were springing up during those years, and how adoption of these various disparate methods allowed us to move forward with our research. It is actually fair to say that the power of these approaches placed on a back burner the questions that we initially asked, by opening up opportunities to go beyond them. For, while we continued studying the effects that transplanted fibroblasts had on the proliferative cells of the hippocampus, it soon became clear that we now had the means to look in a reliable manner at the proliferation of the progenitor cells at their basal level, the phenomenon Joe Altman had studied thirty years before. Members of my lab moved rapidly in this direction, and soon experiments looking at adult neurogenesis in the hippocampus started appearing on the benches. Tantalizingly, we also found that adult-born neurons in the dentate gyrus are generated in a niche containing blood vessels, glia, and endothelial cells. Later studies revealed that these newly generated neurons, which are in fact granule cells, the main component of the dentate gyrus, integrate into the existing hippocampal circuits through a tightly controlled temporal and spatial pattern of migration and subsequent maturation.
Our imagination was captured by the finding by Gerd Kempermann, Georg Kuhn, Henriette van Praag, and many others in the lab showing that adult neurogenesis seemed to be highly regulated Newly born neurons in the adult dentate gyrus labeled with MLV expressing GFP.
''These experiments proved to us that the production of neurons in the dentate gyrus of the hippocampus indeed continues into adulthood. '' by external influences such as exercise, learning, stress, and age. The idea that actions from the outside could modify brain circuitry on a structural level was exciting and unexpected and even more so when we found that seemingly related activities, such as environmental enrichment and physical activity, could have distinct effects on fine tuning the proliferation and survival of adultborn neurons. In fact, the underlying complexity of the process became the refrain of almost every subsequent discovery we made in this field.
The identification of robust neurogenesis in the adult rodent brain made our initial questions even more urgent. What roles did growth factors play in this process? How could we reveal other factors regulating the maturation and integration of these new cells? We were able to tackle these questions thanks to parallel projects in the lab that examined the role of FGF2 in neural progenitor differentiation in vitro and showed that progenitor cells from the dentate gyrus could be harvested from the adult brain and differentiated in culture in the presence of FGF2. This turned out to be an important technical advance, allowing us to monitor and search for mechanisms of adult neurogenesis. Two competing in vitro assays-mono-layer, pioneered by Jaso Ray and Theo Palmer in my lab, and the neurosphere assay promoted by Samuel Weiss and Brent Reynolds were developed-and it was with these assays that many of the mechanisms underpinning adult neurogenesis were explored and later followed up in vivo for validation. It turns out that shepherding such a complex process requires a full toolbox as, in addition to EGF and FGF, the Wnt, Shh, Bmp, notch, and BDNF signaling turned out to play a role in controlling the various stages of the adult neurogenic process. We also found that adult-born neurons matured in two stages in which they displayed distinct properties. The first of these two periods ensured appropriate development of neurons and set their subsequent properties, the other turned out to be important for their ability to function in the hippocampus. While we now know a great deal about the molecular underpinnings of these stages, twenty years on, we and many other groups are still trying to work out how the different signaling systems interact and trigger the maturation stages.
The first question was already a source of considerable controversy, as there had been reports of neurogenesis in the cortex of adult non-human primates, a region that was not considered neurogenic. These findings had been scrutinized but could never be confirmed. We were keen to address this issue and decided to bypass studies in non-human primates altogether, focusing instead on human subjects. This step became possible when, in one of our lab meetings, several visiting clinicians doing sabbaticals in my lab, including Peter Eriksson from Goteborg, Sweden, and Jaana Suhonen from Finland, reminded us that patients with peripheral tumors would receive BrDU injections to either kill the tumor or to provide an indicator of rate of tumor growth by counting the number of positive cells in a biopsy. We contacted some pathology colleagues to locate any collected brains from patients who had died from peripheral tumors and had been injected with BrDU. We obtained some paraffin-embedded brain sections, but although we could detect BrDU labeling in brain cells, due to the nature of the fixative used to preserve the brains, we could not double label the sections with antibodies, so we were not sure what kind of cells they were. Therefore, when Peter Eriksson returned to Sweden, he attached his lab to a cancer study that was following patients with peripheral tumors who had had a BrDU injection. When the patients died, Eriksson and his team sent key brain areas to my lab, where we were working on ways to double label unperfused post-fixed brain tissues. After several years of having enough experts and skeptics examine enough brains, we became convinced that neurogenesis occurred in the human adult brain, and we published our findings in 1998. While our findings were met with initial skepticism, the impact of the work was immediately significant. Human adult neurogenesis has since been confirmed by others using postmortem brains at various ages: perhaps the most intriguing confirmation was published by Kristen Spalding in Jonas Frisé n's lab in 2013. Studying patients exposed to atomic bomb generated radioactivity to carbon-dated neurons, they concluded that adult neurogenesis continued at least until the fifth decade of life. The next step in confirming adult neurogenesis will involve creating an in vivo live-imaging method that can track/monitor neurogenesis in living humans over time and with disease. Inder Verma's lab, with whom we share a space at the Salk, to build a long expressing retrovirus. We reasoned that a retrovirus would be best for labeling adult-born neurons. Since retroviruses only infect and integrate into dividing cells, we could be assured that we would not accidentally infect mature neurons. We labeled the cells by injecting a high titer retrovirus harboring green fluorescent protein (GFP), driven by a strong (CAG) promoter. With this strong promoter and GFP, we could follow the cells indefinitely and stain with multiple markers at various time points to check their fate. But, most importantly, Henriette and Alejandro could patch clamp the GFP-positive neurons in living brain slices to prove they were alive and connected to other neurons in the hippocampus. As a bonus, a new post doc in the lab at the time, Nico Toni, demonstrated with an electron microscope that there were synapses on the dendrites. The first paper on the topic was published in 2002 and marked the first of many functional studies from our lab and other groups that were to follow.
Because the process of neurogenesis has been adequately delineated, computational models made by Brad Aimone when he was in my lab have made specific predictions about the role of the adult-born neurons in hippocampal function and, in particular, in learning and memory. There is an emerging consensus that the dentate gyrus of the hippocampus, in which the adult-born neurons are generated, is crucial for making distinctions between two events that are very similar in their features but are separated in time. This process is called pattern separation computationally, but this term does not seem to capture the biological process adequately. The newborn neurons play an important role in integrating/resolving the two temporally exclusive events when the neurons are in the hyperexcitable phase: they then play a second role-once they are fully mature-in aiding accurate recall of those events that occurred earlier when they were hyperexcitable. The mechanism for how these cells perform their tasks is not fully known, but tremendous progress is being made to define it by different groups around the world.
Twenty years have passed since our initial detection of adult neurogenesis in the mouse dentate gyrus, a discovery that spawned an active and co-operative field. A great number of questions are still open, and disagreements are hotly debated. For instance, whether and to what extent affective behavior is directly regulated or influenced by adult neurogenesis remains contentious. The issue of how long neural stem cells versus neural progenitor cells persist in the life of the organism is not resolved. However, the resolution of these and other points of contention can be empirically derived, which is forcing the use and development of new tools and concepts that are useful to all investigators in the field, and beyond it.
There were some strong skeptics and critics throughout the early days of our work, testing the validity and then the function of adult neurogenesis, and frankly, I worried about technical issues that could be leading us in wrong directions. As in most scientific ventures though, the skeptics and critics drove the research to be more thorough and careful, both technically and conceptually. This experience also prepared me for other uncharted efforts that followed.
